erythrosine has been researched along with Attention Deficit Disorder with Hyperactivity in 2 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Attention Deficit Disorder with Hyperactivity: A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fredriksson, A | 1 |
| Archer, T | 1 |
| Mailman, RB | 1 |
| Lewis, MH | 1 |
2 other studies available for erythrosine and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD.
Topics: Animals; Animals, Newborn; Apoptosis; Attention Deficit Disorder with Hyperactivity; Central Nervous | 2004 |
Food additives and developmental disorders: the case of erythrosin (FD&C Red #3), or guilty until proven innocent?
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Blood-Brain Barrier; Brain Chemistry; Child; | 1981 |